Following the Extraordinary General meeting on 6 July, Christina Herder was elected the new Chair of the board of TikoMed, thereby replacing Juan Vergez, who had been interim chairman since the AGM in early May. Christina Herder has a PhD in Physical Chemistry and has spent most of her career in the pharmaceutical industry. Following … Läs mer
Bjorn Pilstrom
Oslo University Hospital has now begun the inclusion of patients in the IMPACT study, which aims to investigate the efficacy and safety of TikoMed’s candidate drug ILB® compared to riluzole for the treatment of ALS. TikoMed provides ILB® and placebo substance for the study. The study will include 120 patients from all over Norway and … Läs mer
Stockholm 25 February, 2026 The Department of Medicine Solna at Karolinska Institutet and TikoMed AB have signed a letter of intent for a collaboration on a clinical study of ILB® in myocardial infarction. The study is called ILBIAMI and the aim is to evaluate the effect of ILB® in counteracting the consequences of myocardial infarction … Läs mer
TikoMed’s Board of Directors has appointed Dr Björn Pilström as Chief Executive Officer of TikoMed. Dr Pilström has an MD from Karolinska Institutet in Stockholm and a PhD in Immunology from Stockholm University. He has more than 25 years’ global experience from commercial, medical and managerial roles in the life science industry. The former CEO … Läs mer
Senior consultant neurologist Dr Angelina Hatlø Maniaol is coordinating investigator for the study, which will consist of a 6-month double-blind randomized phase where patients will get either Riluzole or ILB®, followed by a 6-month open-label extension where patients will get both ILB® and Riluzole. The study is sponsored by Oslo University Hospital, funded by public … Läs mer
At the Annual General Meeting on 30 June 2025, TikoMed elected a new board of directors for the period until the next general meeting. The three members of the interim board elected in April this year will continue their assignments – Göran Groth as Chairman of the Board and Tobhias Brandell and Lars Bruce as … Läs mer
Vid den ordinarie bolagsstämman den 30 juni 2025 valde TikoMed en ny styrelse för tiden fram till nästa bolagsstämma. De tre ledamöterna från interimsstyrelsen som valdes i april månad fortsätter sina uppdrag – Göran Groth som styrelseordförande och Tobhias Brandell och Lars Bruce som styrelseledamöter. Utöver dessa valde stämman in två nya styrelseledamöter – Anders … Läs mer